Form D · Pharmaceuticals
Zyversa Therapeutics, Inc.
Weston, FL · CIK 0001613083
Offering snapshot reported Apr 14, 2022 · SEC filing
- Reported sold
- $419K Offering amount: $7M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 30, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2022 | Initial | $419,320 | No comparison | 4 | SEC filing |
| Nov 1, 2019 | Initial | $1,277,500 | No comparison | 19 | SEC filing |
| Feb 5, 2018 | Initial | $1,403,627 | No comparison | 20 | SEC filing |
| Mar 2, 2017 | Initial | $525,000 | No comparison | 7 | SEC filing |
| Oct 26, 2016 | Amendment | $1,505,000 | No comparison | 21 | SEC filing |
| Apr 21, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 21, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 3, 2015 | Amendment | $2,980,000 | No comparison | 17 | SEC filing |
| Jul 11, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $560K (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-441861
Assumes maximum commissions earned.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Craft Capital Management LLC | 171350 | |
| Noble Life Science Partners | 15768 |
Source: Form D, filed Apr 14, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karen Cashmere | Executive |
| Robert G Finizio | Director |
| Anthony Giovinazzo | Director |
| Stephen Glover | Director, Executive |
| Aaron Greenblatt | Director |
| Pablo Guzman | Executive |
| Andrew Kim | Director |
| Nick La Bella | Executive |
| Jules Musing | Director |
| Melda Uzbil O'connell | Executive |
| Minchul Park | Director |
| Nico Pronk | Director |
| Eric Richman | Director |
| Shawn M Titcomb | Director |
| Peter Wolfe | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2200 N. Commerce Parkway Suite 208
Weston, FL, 33326
Weston, FL, 33326